Madrigal Pharmaceuticals Inc

MDGL

NASDAQ. Currency in USD

234.83 +171.03 ( +268.07% )

Real time prices: December 19

Market Cap.
4.02B
Beta (5Y monthly)
0.89
Price/Earnings
-
EPS (TTM)
-16.03
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
8.71M
1y Target Est.
152.58
Day's Range
191.49
-
236.39
52 Week's Range
57.15
-
236.39

Historical Summary

Performance
EPS growth
Share Buybacks

About Madrigal Pharmaceuticals Inc

Sector
Healthcare
Industry
Biotechnology
Website
https://www.madrigalpharma.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
17.10M
Employees
71
Address
Four Tower Bridge, West Conshohocken, PA, United States, 19428
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

Latest news

Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced...
By Benzinga - 6 weeks ago

Why Madrigal Pharmaceuticals Stock Is Crushing It Today
Why Madrigal Pharmaceuticals Stock Is Crushing It Today

The company reported stellar late-stage clinical trial results for its experimental NASH (nonalcoholic steatohepatitis) drug.
By The Motley Fool - 6 weeks ago

Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday
Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday

U.S. stocks traded mixed, with the Nasdaq Composite dropping around 90 points on Monday. Here...
By Benzinga - 6 weeks ago

Tesla's Bouncing, but This Nasdaq Stock Tripled Monday Morning
Tesla's Bouncing, but This Nasdaq Stock Tripled Monday Morning

Good news can come in different forms.
By The Motley Fool - 6 weeks ago

Madrigal Pharmaceuticals To Announce Topline Results from the Phase 3 MAESTRO-NASH Study of Resmetirom on Monday, December 19th
Madrigal Pharmaceuticals To Announce Topline Results from the Phase 3 MAESTRO-NASH Study of Resmetirom on Monday, December 19th

CONSHOHOCKEN, Pa., Dec. 18, 2022 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage...
By GlobeNewswire Inc. - 7 weeks ago

2 Healthcare Stocks Poised to Rocket Higher in the 4th Quarter
2 Healthcare Stocks Poised to Rocket Higher in the 4th Quarter

These two healthcare stocks could deliver market-crushing gains by year's end.
By The Motley Fool - 13 weeks ago

Wall Street Thinks These 2 Nasdaq Stocks Could Go Parabolic Soon
Wall Street Thinks These 2 Nasdaq Stocks Could Go Parabolic Soon

NASH is a common disease, but there are no approved treatments for it. These two...
By The Motley Fool - 20 weeks ago